PLSE - Pulse Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
331.67M
Enterprise Value 3
287.31M
Trailing P/E
N/A
Forward P/E 1
-8.19
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
6.65
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-7.06

Trading Information

Stock Price History

Beta (3Y Monthly) 1.96
52-Week Change 364.23%
S&P500 52-Week Change 39.71%
52 Week High 319.77
52 Week Low 38.60
50-Day Moving Average 314.69
200-Day Moving Average 313.34

Share Statistics

Avg Vol (3 month) 347.7k
Avg Vol (10 day) 361.23k
Shares Outstanding 520.77M
Float 9.8M
% Held by Insiders 159.60%
% Held by Institutions 18.62%
Shares Short (Sep 30, 2019) 42.52M
Short Ratio (Sep 30, 2019) 440.59
Short % of Float (Sep 30, 2019) 422.57%
Short % of Shares Outstanding (Sep 30, 2019) 412.11%
Shares Short (prior month Aug 30, 2019) 42.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-54.37%
Return on Equity (ttm)-96.93%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -40.7M
Net Income Avi to Common (ttm)-41.15M
Diluted EPS (ttm)-2.17
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)42.64M
Total Cash Per Share (mrq)2.05
Total Debt (mrq)3.89M
Total Debt/Equity (mrq)7.81
Current Ratio (mrq)12.92
Book Value Per Share (mrq)2.40

Cash Flow Statement

Operating Cash Flow (ttm)-30.18M
Levered Free Cash Flow (ttm)-14.9M